Skip to main content
Top
Published in: Internal and Emergency Medicine 7/2017

01-10-2017 | CE - ORIGINAL

Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin

Authors: Raffaele Manna, Roberto Cauda, Sandro Feriozzi, Giovanni Gambaro, Antonio Gasbarrini, Didier Lacombe, Avi Livneh, Alberto Martini, Huri Ozdogan, Antonio Pisani, Eleonora Riccio, Elena Verrecchia, Lorenzo Dagna, International Panel for RAre recurrent FUO-IPRAFUO

Published in: Internal and Emergency Medicine | Issue 7/2017

Login to get access

Abstract

Fever of unknown origin (FUO) is a rather rare clinical syndrome representing a major diagnostic challenge. The occurrence of more than three febrile attacks with fever-free intervals of variable duration during 6 months of observation has recently been proposed as a subcategory of FUO, Recurrent FUO (RFUO). A substantial number of patients with RFUO have auto-inflammatory genetic fevers, but many patients remain undiagnosed. We hypothesize that this undiagnosed subgroup may be comprised of, at least in part, a number of rare genetic febrile diseases such as Fabry disease. We aimed to identify key features or potential diagnostic clues for Fabry disease as a model of rare genetic febrile diseases causing RFUO, and to develop diagnostic guidelines for RFUO, using Fabry disease as an example of inserting other rare diseases in the existing FUO algorithms. An international panel of specialists in recurrent fevers and rare diseases, including internists, infectious disease specialists, rheumatologists, gastroenterologists, nephrologists, and medical geneticists convened to review the existing diagnostic algorithms, and to suggest recommendations for arriving at accurate diagnoses on the basis of available literature and clinical experience. By combining specific features of rare diseases with other diagnostic considerations, guidelines have been designed to raise awareness and identify rare diseases among other causes of FUO. The proposed guidelines may be useful for the inclusion of rare diseases in the diagnostic algorithms for FUO. A wide spectrum of patients will be needed to validate the algorithm in different clinical settings.
Appendix
Available only for authorised users
Literature
1.
go back to reference Petersdorf RG, Beeson PB (1961) Fever of unexplained origin: report on 100 cases. Medicine (Baltimore) 40:1–30CrossRef Petersdorf RG, Beeson PB (1961) Fever of unexplained origin: report on 100 cases. Medicine (Baltimore) 40:1–30CrossRef
2.
go back to reference Durack DT, Street AC (1991) Fever of unknown origin—re-examined and redefined. Curr Clin Top Infect Dis 11:35–51PubMed Durack DT, Street AC (1991) Fever of unknown origin—re-examined and redefined. Curr Clin Top Infect Dis 11:35–51PubMed
3.
go back to reference Knockaert DC, Vanderschueren S, Blockmans D (2003) Fever of unknown origin in adults: 40 years on. J Intern Med 253(3):263–275CrossRefPubMed Knockaert DC, Vanderschueren S, Blockmans D (2003) Fever of unknown origin in adults: 40 years on. J Intern Med 253(3):263–275CrossRefPubMed
4.
go back to reference Knockaert DC (2007) Recurrent fevers of unknown origin. Infect Dis Clin N Am 21:1189–1211CrossRef Knockaert DC (2007) Recurrent fevers of unknown origin. Infect Dis Clin N Am 21:1189–1211CrossRef
5.
go back to reference Knockaert DC, Vanneste LJ, Bobbaers HJ (1993) Recurrent or episodic fever of unknown origin: review of 45 cases and survey of the literature. Medicine 72(3):184–196CrossRefPubMed Knockaert DC, Vanneste LJ, Bobbaers HJ (1993) Recurrent or episodic fever of unknown origin: review of 45 cases and survey of the literature. Medicine 72(3):184–196CrossRefPubMed
6.
go back to reference Baldovino S, Moliner AM, Taruscio D, Daina E, Roccatello D (2016) Rare diseases in Europe: from a wide to a local perspective. Isr Med Assoc J 18(6):359–363PubMed Baldovino S, Moliner AM, Taruscio D, Daina E, Roccatello D (2016) Rare diseases in Europe: from a wide to a local perspective. Isr Med Assoc J 18(6):359–363PubMed
7.
go back to reference Chao CT, Yang CC, Kao TW (2012) Fabry disease: a rare cause of fever of unknown origin. Am J Kidney Dis 59(1):161–162CrossRefPubMed Chao CT, Yang CC, Kao TW (2012) Fabry disease: a rare cause of fever of unknown origin. Am J Kidney Dis 59(1):161–162CrossRefPubMed
8.
go back to reference Marchesoni CL, Roa N, Pardal AM, Neumann P, Cáceres G, Martínez P, Kisinovsky I, Bianchi S, Tarabuso AL, Reisin RC (2010) Misdiagnosis in Fabry disease. J Pediatr 156(5):828–831CrossRefPubMed Marchesoni CL, Roa N, Pardal AM, Neumann P, Cáceres G, Martínez P, Kisinovsky I, Bianchi S, Tarabuso AL, Reisin RC (2010) Misdiagnosis in Fabry disease. J Pediatr 156(5):828–831CrossRefPubMed
9.
go back to reference Lidove O, Kaminsky P, Hachulla E, Leguy-Seguin V, Lavigne C, Marie I, Maillot F, Serratrice C, Masseau A, Chérin P, Cabane J (2012) Noel E; FIMeD investigators. Fabry disease ‘The New Great Imposter’: results of the French Observatoire in Internal Medicine Departments (FIMeD). Clin Genet 81(6):571–577CrossRefPubMed Lidove O, Kaminsky P, Hachulla E, Leguy-Seguin V, Lavigne C, Marie I, Maillot F, Serratrice C, Masseau A, Chérin P, Cabane J (2012) Noel E; FIMeD investigators. Fabry disease ‘The New Great Imposter’: results of the French Observatoire in Internal Medicine Departments (FIMeD). Clin Genet 81(6):571–577CrossRefPubMed
10.
go back to reference Verrecchia E, Zampetti A, Antuzzi D, Ricci R, Ferri L, Morrone A, Feliciani C, Dagna L, Manna R (2016) The impact of fever/hyperthermia in the diagnosis of Fabry: a retrospective analysis. Eur J Intern Med 32:26–30CrossRefPubMed Verrecchia E, Zampetti A, Antuzzi D, Ricci R, Ferri L, Morrone A, Feliciani C, Dagna L, Manna R (2016) The impact of fever/hyperthermia in the diagnosis of Fabry: a retrospective analysis. Eur J Intern Med 32:26–30CrossRefPubMed
11.
go back to reference Mehta A, Hughes DA (2002) Fabry Disease. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K (eds) GeneReviews® [Internet]. University of Washington, Seattle; 1993–2017 (updated 2017 Jan 5) Mehta A, Hughes DA (2002) Fabry Disease. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K (eds) GeneReviews® [Internet]. University of Washington, Seattle; 1993–2017 (updated 2017 Jan 5)
12.
go back to reference Schiffmann R, Ries M (2016) Fabry disease: a disorder of childhood onset. Pediatr Neurol 64:10–20CrossRefPubMed Schiffmann R, Ries M (2016) Fabry disease: a disorder of childhood onset. Pediatr Neurol 64:10–20CrossRefPubMed
13.
go back to reference Seydelmann N, Wanner C, Störk S, Ertl G (2015) Weidemann F Fabry disease and the heart. Best Pract Res Clin Endocrinol Metab 29(2):195–204CrossRefPubMed Seydelmann N, Wanner C, Störk S, Ertl G (2015) Weidemann F Fabry disease and the heart. Best Pract Res Clin Endocrinol Metab 29(2):195–204CrossRefPubMed
14.
go back to reference van der Tol L, Smid BE, Poorthuis BJ, Biegstraaten M, Deprez RH, Linthorst GE et al (2014) A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance. J Med Genet 51:1–9CrossRefPubMed van der Tol L, Smid BE, Poorthuis BJ, Biegstraaten M, Deprez RH, Linthorst GE et al (2014) A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance. J Med Genet 51:1–9CrossRefPubMed
15.
go back to reference Reisin R, Perrin A, García-Pavía P (2017) Time delays in the diagnosis and treatment of Fabry disease. Int J Clin Pract 71(1). doi:10.1111/ijcp.12914 Reisin R, Perrin A, García-Pavía P (2017) Time delays in the diagnosis and treatment of Fabry disease. Int J Clin Pract 71(1). doi:10.​1111/​ijcp.​12914
16.
go back to reference Thomas AS, Mehta AB (2013) Difficulties and barriers in diagnosing Fabry disease: what can be learnt from the literature? Expert Opin Med Diagn 7(6):589–599CrossRefPubMed Thomas AS, Mehta AB (2013) Difficulties and barriers in diagnosing Fabry disease: what can be learnt from the literature? Expert Opin Med Diagn 7(6):589–599CrossRefPubMed
17.
go back to reference Tabak F, Mert A, Celik AD, Ozaras R, Altiparmak MR, Ozturk R, Aktuglu Y (2003) Fever of unknown origin in Turkey. Infection 31(6):417–420PubMed Tabak F, Mert A, Celik AD, Ozaras R, Altiparmak MR, Ozturk R, Aktuglu Y (2003) Fever of unknown origin in Turkey. Infection 31(6):417–420PubMed
18.
go back to reference Bleeker-Rovers CP, Vos FJ, de Kleijn EM, Mudde AH, Dofferhoff TS, Richter C, Smilde TJ, Krabbe PF, Oyen WJ, van der Meer JW (2007) A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore) 86(1):26–38CrossRef Bleeker-Rovers CP, Vos FJ, de Kleijn EM, Mudde AH, Dofferhoff TS, Richter C, Smilde TJ, Krabbe PF, Oyen WJ, van der Meer JW (2007) A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore) 86(1):26–38CrossRef
19.
go back to reference Nicolotti N, Cattel C, Gualano M, Soriano A, Manna R, Boccia S (2013) A retrospective analysis of 3156 admissions with fever of unknown origin in a large Italian hospital. Epidemiology, Biostatistics and Public Health. (Dicembre): pe8776-1-pe8776-7 (Available at: ebph.it/article/download/8776/8221) Nicolotti N, Cattel C, Gualano M, Soriano A, Manna R, Boccia S (2013) A retrospective analysis of 3156 admissions with fever of unknown origin in a large Italian hospital. Epidemiology, Biostatistics and Public Health. (Dicembre): pe8776-1-pe8776-7 (Available at: ebph.it/article/download/8776/8221)
20.
go back to reference Wolf H, Graninger W (2003) Cost-effectiveness in diagnosis of patients with long-standing fever. Wien Med Wochenschr 153(9–10):202–207CrossRefPubMed Wolf H, Graninger W (2003) Cost-effectiveness in diagnosis of patients with long-standing fever. Wien Med Wochenschr 153(9–10):202–207CrossRefPubMed
21.
go back to reference Pisani A, Visciano B, Imbriaco M, Di Nuzzi A, Mancini A, Marchetiello C, Riccio E (2014) The kidney in Fabry’s disease. Clin Genet 86(4):301–309CrossRefPubMed Pisani A, Visciano B, Imbriaco M, Di Nuzzi A, Mancini A, Marchetiello C, Riccio E (2014) The kidney in Fabry’s disease. Clin Genet 86(4):301–309CrossRefPubMed
22.
go back to reference Mignani R, Gallieni M, Feriozzi S, Pisani A, Marziliano N, Morrone A (2015) The nephropathy in the Anderson–Fabry disease: new recommendations for the diagnosis, the follow-up and the therapy. G Ital Nefrol 32(4) Mignani R, Gallieni M, Feriozzi S, Pisani A, Marziliano N, Morrone A (2015) The nephropathy in the Anderson–Fabry disease: new recommendations for the diagnosis, the follow-up and the therapy. G Ital Nefrol 32(4)
23.
go back to reference Debette S, Germain DP (2014) Neurologic manifestations of inherited disorders of connective tissue. Handb Clin Neurol 119:565–576CrossRefPubMed Debette S, Germain DP (2014) Neurologic manifestations of inherited disorders of connective tissue. Handb Clin Neurol 119:565–576CrossRefPubMed
24.
go back to reference Biegstraaten M, Linthorst GE, van Schaik IN, Hollak CE (2013) Fabry disease: a rare cause of neuropathic pain. Curr Pain Headache Rep 17(10):365CrossRefPubMed Biegstraaten M, Linthorst GE, van Schaik IN, Hollak CE (2013) Fabry disease: a rare cause of neuropathic pain. Curr Pain Headache Rep 17(10):365CrossRefPubMed
26.
go back to reference Hagège AA, Germain DP (2015) Adult patients with Fabry disease: what does the cardiologist need to know? Heart 101(12):916–918CrossRefPubMed Hagège AA, Germain DP (2015) Adult patients with Fabry disease: what does the cardiologist need to know? Heart 101(12):916–918CrossRefPubMed
27.
go back to reference Zampetti A, Orteu CH, Antuzzi D, Bongiorno MR, Manco S, Gnarra M, Morrone A, Cardinali G, Kovacs D, Aspite N, Linder D, Parini R (2012) Feliciani C; Interdisciplinary Study Group on Fabry Disease (ISGF). Angiokeratoma: decision-making aid for the diagnosis of Fabry disease. Br J Dermatol 166(4):712–720CrossRefPubMed Zampetti A, Orteu CH, Antuzzi D, Bongiorno MR, Manco S, Gnarra M, Morrone A, Cardinali G, Kovacs D, Aspite N, Linder D, Parini R (2012) Feliciani C; Interdisciplinary Study Group on Fabry Disease (ISGF). Angiokeratoma: decision-making aid for the diagnosis of Fabry disease. Br J Dermatol 166(4):712–720CrossRefPubMed
29.
go back to reference Morrone A, Cavicchi C, Bardelli T, Antuzzi D, Parini R, Di Rocco M, Feriozzi S, Gabrielli O, Barone R, Pistone G, Spisni C, Ricci R, Zammarchi E (2003) Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers. J Med Genet 40(8):e103CrossRefPubMedPubMedCentral Morrone A, Cavicchi C, Bardelli T, Antuzzi D, Parini R, Di Rocco M, Feriozzi S, Gabrielli O, Barone R, Pistone G, Spisni C, Ricci R, Zammarchi E (2003) Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers. J Med Genet 40(8):e103CrossRefPubMedPubMedCentral
30.
go back to reference Echevarria L, Benistan K, Toussaint A, Dubourg O, Hagege AA, Eladari D, Jabbour F, Beldjord C, De Mazancourt P, Germain DP (2016) X-chromosome inactivation in female patients with Fabry disease. Clin Genet 89(1):44–54CrossRefPubMed Echevarria L, Benistan K, Toussaint A, Dubourg O, Hagege AA, Eladari D, Jabbour F, Beldjord C, De Mazancourt P, Germain DP (2016) X-chromosome inactivation in female patients with Fabry disease. Clin Genet 89(1):44–54CrossRefPubMed
Metadata
Title
Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin
Authors
Raffaele Manna
Roberto Cauda
Sandro Feriozzi
Giovanni Gambaro
Antonio Gasbarrini
Didier Lacombe
Avi Livneh
Alberto Martini
Huri Ozdogan
Antonio Pisani
Eleonora Riccio
Elena Verrecchia
Lorenzo Dagna
International Panel for RAre recurrent FUO-IPRAFUO
Publication date
01-10-2017
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 7/2017
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-017-1704-y

Other articles of this Issue 7/2017

Internal and Emergency Medicine 7/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine